BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.01) earnings per share for the quarter, Zacks reports.
BioNxt Solutions Stock Performance
OTCMKTS:BNXTF remained flat at $0.28 on Friday. The company’s stock had a trading volume of 2,000 shares, compared to its average volume of 1,006. BioNxt Solutions has a 12 month low of $0.14 and a 12 month high of $0.79. The company has a 50-day moving average of $0.23 and a 200 day moving average of $0.32. The firm has a market capitalization of $37.60 million, a price-to-earnings ratio of -5.53 and a beta of 0.70.
BioNxt Solutions Company Profile
BioNxt Solutions Inc (OTCMKTS:BNXTF) is a life sciences company specializing in advanced proteomics, metabolomics and bioinformatics solutions. The company’s platform combines state-of-the-art mass spectrometry and chromatography workflows with cloud-based data analysis tools, enabling high-throughput characterization of proteins, metabolites and other biomolecules for research and development purposes.
BioNxt Solutions offers contract research services to clients in the pharmaceutical, biotechnology and academic sectors, providing end-to-end support from sample preparation through to data interpretation.
Read More
- Five stocks we like better than BioNxt Solutions
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
- BWX Technologies’ Army Reactor Win Could Redraw Its Nuclear Growth Story
- Meta’s $18 Billion Settlement May Be a Win for Investors
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
